Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a717ea5b2ac78ac329ab3a9659d834d2 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S930-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S930-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S930-28 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-6555 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-655 |
filingDate |
1975-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
1976-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3455e67e3d28fedc5223f562f16b81a6 |
publicationDate |
1976-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-3991041-A |
titleOfInvention |
(Phe3 -Ala)1 -somatostatin |
abstract |
The growth hormone release inhibiting compound: H-Phe-Phe-Phe-Ala-Gly-Cys-Lys-Asn-Phe-Phe- ¦ Trp-Lys-Thr-Phe-Thr-Ser-Cys-A, the corresponding linear heptadecapeptide, non-toxic acid addition salts and intermediates therefore are herein described, in which Trp is D-tryptophyl or L-tryptophyl and each of the other optically active amino acid moieties are of the L-configuration and A represents -OH, -NH2, dimethylamino, alkylamino of 1-5 carbon atoms or phenethylamino. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4428942-A |
priorityDate |
1975-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |